SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

TATIA GLOBAL VENNTURE

BSE: 521228 01 Jun 2025
Consumer Discretionary
₹ 2.81
Tatia Global Vennture Limited specializes in Residential- Commercial Projects within the Consumer Discretionary sector.

TATIA GLOBAL VENNTURE - Share Price & Details

Market Cap
₹45.0
High /Low
4.4 / 2.41
Stock P/E
5.88
Book Value
₹2.06
Dividend Yield
0.0
ROCE
25.8
ROE
₹26.5
Face Value
1.0
PEG Ratio
0.23
EVEBITDA
₹5.31
Debt
0.00
CMP / FCF
26.5
Debt to equity
₹0.0
NP Ann
7.66
High price all time
32.7
Piotroski score
₹8.0
Graham Number
4.84
No. Eq. Shares
15.2
Net CF
₹3.24
Net profit
7.66
Price to book value
1.44
Interest Coverage
₹NA
Low price all time
0.11
Industry PE
39.3
Reserves
₹16.1
Free Cash Flow
₹5.00

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Tivoli Construction Ltd.,NANANANA0
Tata Motors Ltd.NANANANA0NA
TATIA GLOBAL VENNTURE LTD.NANANANA45.05.88
MANJEERA CONSTRUCTIONS LTD.NANANANA45
BLUE COAST HOTELS LTD.0.26-31.670.0-1.6544.9

Peer Comparison Chart


About TATIA GLOBAL VENNTURE

Tatia Global Vennture Limited, with Security Code 521228, is a leading player in the Residential- Commercial Projects industry, categorized under the Consumer Discretionary sector, offering Equity instruments.


Latest News

Tatia Global Standalone March 2025 Net Sales at Rs 0.38 crore, up 45.98% Y-o-Y

(29 May 2025)
Net Sales at Rs 0.38 crore in March 2025 up 45.98% from Rs. 0.26 crore in March 2024. Story continues below Advertisement.
Read more →

Tatia Global Venture Reports Significant Profit Surge and Evaluation Shift in May 2025

(28 May 2025)
Tatia Global Venture has announced its financial results for the quarter ending March 2025, revealing a significant increase in Profit After Tax (PAT) to Rs...
Read more →

Tatia Global Venture consolidated net profit rises 60.00% in the March 2025 quarter

(27 May 2025)
Sales rise 46.15% to Rs 0.38 crore. Net profit of Tatia Global Venture rose 60.00% to Rs 0.24 crore in the quarter ended March 2025 as against Rs 0.15 crore...
Read more →

Q4 results: Aurobindo Pharma, Shilpa Medicare, Nazara Technologies to announce March quarter numbers on May 26; check details

(26 May 2025)
Auropbindo Pharma, Shilpa Medicare, Yathath Hospital, Nazara Technologies, Olectra Greentech, Orchid Pharma, RateGain Travel technologies...
Read more →

Earnings Today Alert: General Insurance Corp, Aurobindo Pharma, Sundaram Finance & 200+ Firms Set To Report Q4 Results

(26 May 2025)
The Indian stock market is poised for an action-packed day as over 200 companies are scheduled to announce their Q4 earnings.
Read more →

PVP Ventures Limited acquires majority stake in Biohygea Global Private Limited

(24 Apr 2025)
PVP Ventures Ltd., ("PVP") executed binding agreements to acquire 52% stake in Biohygea Global Private Limited ("Medilab"/ "Company").
Read more →